InsideArbitrage Event Driven Monitor – October 22, 2025

HOLX: The acquisition of Hologic, Inc. (HOLX) by Blackstone (BX) and TPG (TPG) for a closing value of $18.3 billion. Blackstone and TPG will acquire all outstanding Hologic shares for $76 per share in cash plus a non-tradable contingent value right (CVR) to receive up to $3 per share in two payments of up to $1.50 each, for total consideration of up to $79 per share in cash. The non-tradable CVR would be issued to Hologic stockholders at closing and paid following achievement of certain global revenue goals for Hologic’s Breast Health business in the years 2026 and 2027. The cash price of $76 represents a premium of 5.75% from the stock’s last close. (Press Release)
CORZ: Bloomberg reported that CoreWeave (CRWV) won’t increase its offer for data center provider Core Scientific (CORZ), despite opposition to the deal from major shareholders. “We’re very comfortable that the way that we have priced it is appropriate for us,” Chief Executive Officer Michael Intrator said on stage at Bloomberg Technology in London.
MRUS: Genmab Holding II B.V., a wholly owned subsidiary of Genmab (GMAB), commenced the tender offer to acquire Merus (MRUS) for $97 per share in cash. The offer will expire on December 11, 2025.

You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.

Only plus or premium subscribers can access this post. Subscribe today.

Subscribe Today